These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 9768629

  • 1. Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
    Moorman AC, Von Bargen JC, Palella FJ, Holmberg SD.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):182-8. PubMed ID: 9768629
    [Abstract] [Full Text] [Related]

  • 2. [Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
    Groll AH, Ritter J, Müller FM.
    Klin Padiatr; 2001 Sep 01; 213 Suppl 1():A38-49. PubMed ID: 11577363
    [Abstract] [Full Text] [Related]

  • 3. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
    Simonds RJ, Hughes WT, Feinberg J, Navin TR.
    Clin Infect Dis; 1995 Aug 01; 21 Suppl 1():S44-8. PubMed ID: 8547511
    [Abstract] [Full Text] [Related]

  • 4. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
    Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA.
    Arch Intern Med; 2002 Apr 22; 162(8):921-8. PubMed ID: 11966344
    [Abstract] [Full Text] [Related]

  • 5. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
    Yangco BG, Von Bargen JC, Moorman AC, Holmberg SD.
    Ann Intern Med; 2000 Feb 01; 132(3):201-5. PubMed ID: 10651600
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
    Prosty C, Katergi K, Sorin M, Rjeily MB, Butler-Laporte G, McDonald EG, Lee TC.
    Clin Microbiol Infect; 2024 Jul 01; 30(7):866-876. PubMed ID: 38583518
    [Abstract] [Full Text] [Related]

  • 7. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC, Rimland D.
    Pharmacotherapy; 1996 Jul 01; 16(6):1030-8. PubMed ID: 8947975
    [Abstract] [Full Text] [Related]

  • 8. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ, Hoover DR, Peng Y, Phair JP, Visscher B, Kingsley LA, Schrager LK.
    JAMA; 1995 Apr 19; 273(15):1197-202. PubMed ID: 7707627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F, Saba J, Micoud M, Mouton Y, Canton P.
    J Acquir Immune Defic Syndr (1988); 1994 May 19; 7(5):457-62. PubMed ID: 8158539
    [Abstract] [Full Text] [Related]

  • 12. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
    Koch A, Kothe H, Braun J, Kämmerer R, Friedrich HJ, Dalhoff K.
    Pneumologie; 1998 Nov 19; 52(11):614-21. PubMed ID: 9885511
    [Abstract] [Full Text] [Related]

  • 13. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
    Korraa H, Saadeh C.
    South Med J; 1996 Mar 19; 89(3):272-7. PubMed ID: 8604455
    [Abstract] [Full Text] [Related]

  • 14. Optimizing PCP therapy.
    Torres G, Cadman J.
    GMHC Treat Issues; 1997 Oct 19; 11(10):3-5. PubMed ID: 11364821
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
    Sackoff J, McFarland J, Su S, Bryan E.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):387-92. PubMed ID: 9833748
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ, Hauptman SP.
    Clin Pharm; 1988 Jul 01; 7(7):514-27. PubMed ID: 3138063
    [Abstract] [Full Text] [Related]

  • 17. The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
    Hughes WT.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar 01; 8(3):247-52. PubMed ID: 7859136
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC, Griffith L, Guyatt GH, Opravil M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun 01; 15(2):104-14. PubMed ID: 9241108
    [Abstract] [Full Text] [Related]

  • 20. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
    Nielsen TL, Jensen BN, Nelsing S, Mathiesen LR, Skinhøj P, Nielsen JO.
    Scand J Infect Dis; 1995 Jun 01; 27(3):217-20. PubMed ID: 8539544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.